# Boston Scientific Corporation (BSX) — Q3-2012 Earnings Results

**Report date:** 2012-10-18 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q3-2012

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 3.9%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.16 | N/A | +46.79% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of optimism about the company's direction. They emphasized the importance of innovation and market expansion.

**Key quotes:**

> Management highlighted strong performance in key product areas.

> They expressed confidence in long-term growth despite current market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report shows a significant beat on EPS, which indicates better-than-expected profitability. However, the stock fell by 3.9%, likely due to investor concerns over the lack of revenue data and guidance. This reaction suggests that while the EPS surprise is positive, uncertainty about future performance may be weighing on investor sentiment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q3-2012_